| Interactional influence of fatigue and task difficulty on cardiovascular response: Demonstrations involving an aerobic exercise challenge RA Wright, JJ Shim, BK Hogan, J Duncan, C Thomas Psychophysiology 49 (8), 1049-1058, 2012 | 48 | 2012 |
| Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US … A Drakaki, PK Dhillon, H Wakelee, SY Chui, J Shim, M Kent, V Degaonkar, ... Oncoimmunology 9 (1), 1824645, 2020 | 38 | 2020 |
| Associations between friends' disordered eating and muscle-enhancing behaviors ME Eisenberg, M Wall, JJ Shim, M Bruening, K Loth, D Neumark-Sztainer Social Science & Medicine 75 (12), 2242-2249, 2012 | 32 | 2012 |
| Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer … A Drakaki, P Luhn, H Wakelee, PK Dhillon, M Kent, J Shim, V Degaonkar, ... Annals of Oncology 30, xi16-xi17, 2019 | 24 | 2019 |
| Geographic variation in the quality and cost of care for patients with rheumatoid arthritis J Shafrin, A Ganguli, YS Gonzalez, JJ Shim, SA Seabury Journal of managed care & specialty pharmacy 22 (12), 1472-1481, 2016 | 16 | 2016 |
| Erythropoiesis-stimulating agent use after changes in medicare reimbursement policies DL Hershman, AI Neugut, JJ Shim, S Glied, WY Tsai, JD Wright Journal of Oncology Practice 10 (4), 264-269, 2014 | 13 | 2014 |
| Wearable-based accelerometer activity profile as digital biomarker of inflammation, biological age, and mortality using hierarchical clustering analysis in NHANES 2011–2014 J Shim, E Fleisch, F Barata Scientific Reports 13 (1), 9326, 2023 | 10 | 2023 |
| Reconsidering the economic value of multiple sclerosis therapies Y Liu, JJ Shim, D Lakdawalla The American Journal of Managed Care 22 (11), e368-e374, 2016 | 9 | 2016 |
| Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer BA Spencer, JJ Shim, DL Hershman, BE Zacharia, EA Lim, MC Benson, ... Supportive Care in Cancer 22, 1549-1555, 2014 | 8 | 2014 |
| Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study T Sanglier, J Shim, N Lamarre, C Peña-Murillo, V Antao, F Montemurro The Breast 69, 441-450, 2023 | 5 | 2023 |
| Geographic variation in diagnostic ability and quality of care metrics: A case study of ankylosing spondylitis and low back pain J Shafrin, J Griffith, JJ Shim, C Huber, A Ganguli, W Aubry INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2017 | 5 | 2017 |
| Comparative efficacy of commercial wearables for circadian rhythm home monitoring from activity, heart rate, and core body temperature F Wu, P Langer, J Shim, E Fleisch, F Barata arXiv preprint arXiv:2404.03408, 2024 | 2 | 2024 |
| Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study … L Polito, J Shim, SA Hurvitz, CT Dang, A Knott, Y Du Toit, E Restuccia, ... JCO Oncology Practice 19 (7), 435-445, 2023 | 2 | 2023 |
| Is friendship network weight status associated with one's own psychological well-being? It depends on one's own weight status PT Fuglestad, MM Wall, JJ Shim, ME Eisenberg, D Neumark-Sztainer Journal of social and clinical psychology 35 (5), 401-424, 2016 | 2 | 2016 |
| Wearable-based physical activity as a digital biomarker of inflammation, biological age, and mortality: a hierarchical clustering analysis of NHANES 2011-2014. 2023 J Shim, E Fleisch, F Barata | 1 | 2023 |
| 252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world … C Labaki, Z Bakouny, T Sanglier, A Schmidt, J Shim, DA Braun, F Bouquet, ... Annals of Oncology 33, S652, 2022 | 1 | 2022 |
| Clinical characteristics and real-world progression-free survival (rwPFS) of patients with HER2-positive and hormone receptor (HR)-positive metastatic breast cancer (MBC … T Sanglier, J Shim, D Eiger, R Poppe, E Restuccia Journal of Clinical Oncology 40 (16_suppl), e13028-e13028, 2022 | 1 | 2022 |
| Abstract P1-18-14: Use of pertuzumab in combination with taxanes for HER2+ metastatic breast cancer: analysis of US electronic health records L Polito, J Shim, YD Toit, T Do, A Knott, T Sanglier Cancer Research 80 (4_Supplement), P1-18-14-P1-18-14, 2020 | 1 | 2020 |
| Use of pertuzumab in combination with taxanes for HER2+ metastatic breast cancer: Analysis of US electronic health records L Polito, J Shim, Y Du Toit, T Do, A Knott, T Sanglier CANCER RESEARCH 80 (4), 2020 | 1 | 2020 |
| The value of novel immuno-oncology treatments. JA Romley, A Delgado, J Shim, K Batt The American journal of managed care 24 (12), e380-e385, 2018 | 1 | 2018 |
